Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
N-(cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase 2. N-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agent.
Misra RN, Xiao HY, Kim KS, Lu S, Han WC, Barbosa SA, Hunt JT, Rawlins DB, Shan W, Ahmed SZ, Qian L, Chen BC, Zhao R, Bednarz MS, Kellar KA, Mulheron JG, Batorsky R, Roongta U, Kamath A, Marathe P, Ranadive SA, Sack JS, Tokarski JS, Pavletich NP, Lee FY, Webster KR, Kimball SD. Misra RN, et al. Among authors: barbosa sa. J Med Chem. 2004 Mar 25;47(7):1719-28. doi: 10.1021/jm0305568. J Med Chem. 2004. PMID: 15027863
Discovery and preclinical studies of (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an in vivo active potent VEGFR-2 inhibitor.
Bhide RS, Cai ZW, Zhang YZ, Qian L, Wei D, Barbosa S, Lombardo LJ, Borzilleri RM, Zheng X, Wu LI, Barrish JC, Kim SH, Leavitt K, Mathur A, Leith L, Chao S, Wautlet B, Mortillo S, Jeyaseelan R Sr, Kukral D, Hunt JT, Kamath A, Fura A, Vyas V, Marathe P, D'Arienzo C, Derbin G, Fargnoli J. Bhide RS, et al. J Med Chem. 2006 Apr 6;49(7):2143-6. doi: 10.1021/jm051106d. J Med Chem. 2006. PMID: 16570908
Discovery of brivanib alaninate ((S)-((R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), a novel prodrug of dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinase inhibitor (BMS-540215).
Cai ZW, Zhang Y, Borzilleri RM, Qian L, Barbosa S, Wei D, Zheng X, Wu L, Fan J, Shi Z, Wautlet BS, Mortillo S, Jeyaseelan R Sr, Kukral DW, Kamath A, Marathe P, D'Arienzo C, Derbin G, Barrish JC, Robl JA, Hunt JT, Lombardo LJ, Fargnoli J, Bhide RS. Cai ZW, et al. J Med Chem. 2008 Mar 27;51(6):1976-80. doi: 10.1021/jm7013309. Epub 2008 Feb 21. J Med Chem. 2008. PMID: 18288793
Correction to N-(Cycloalkylamino)acyl-2-aminothiazole Inhibitors of Cyclin-Dependent Kinase 2. N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide (BMS-387032), a Highly Efficacious and Selective Antitumor Agent.
Misra RN, Xiao HY, Kim KS, Lu S, Han WC, Barbosa SA, Hunt JT, Rawlins DB, Shan W, Ahmed SZ, Qian L, Chen BC, Zhao R, Bednarz MS, Kellar KA, Mulheron JG, Batorsky R, Roongta U, Kamath A, Marathe P, Ranadive SA, Sack JS, Tokarski JS, Pavletich NP, Lee FY, Webster KR, Kimball SD. Misra RN, et al. Among authors: barbosa sa. J Med Chem. 2015 Sep 24;58(18):7609. doi: 10.1021/acs.jmedchem.5b01294. Epub 2015 Sep 2. J Med Chem. 2015. PMID: 26328598 No abstract available.
Pyrrolopyridazine MEK inhibitors.
Chen Z, Kim SH, Barbosa SA, Huynh T, Tortolani DR, Leavitt KJ, Wei DD, Manne V, Ricca CS, Gullo-Brown J, Poss MA, Vaccaro W, Salvati ME. Chen Z, et al. Among authors: barbosa sa. Bioorg Med Chem Lett. 2006 Feb;16(3):628-32. doi: 10.1016/j.bmcl.2005.10.052. Epub 2005 Nov 3. Bioorg Med Chem Lett. 2006. PMID: 16275076
Association between Arterial Stiffness and Higher Burden of Atrial Arrhythmia in Elderly Hypertensive Patients without Atrial Fibrillation.
Lage JGB, Bortolotto AL, Bortolotto LA, Verardino RGS, Pessente GD, Bihan DCSL, Barretto RBM, Consolim-Colombo FM, Hachul DT, Sacilotto L, Wu TC, Bueno SCP, Rivarola EWR, Gruppi CJ, Barbosa SA, Alves JBS, Mathias W, Scanavacca MI, Darrieux FCC. Lage JGB, et al. Among authors: barbosa sa. Arq Bras Cardiol. 2024 Oct 18;121(10):e20240251. doi: 10.36660/abc.20240251. eCollection 2024. Arq Bras Cardiol. 2024. PMID: 39442141 Free PMC article. English, Portuguese.
Antifungal activity of tannic acid against Candida spp. and its mechanism of action.
Moreira LEA, de Farias Cabral VP, Rodrigues DS, Barbosa AD, Silveira MJCB, Coutinho TDNP, Barbosa SA, Sá LGDAV, de Andrade Neto JB, da Rocha SNC, Reis CS, Cavalcanti BC, Rios MEF, de Moraes MO, Júnior HVN, da Silva CR. Moreira LEA, et al. Among authors: barbosa sa. Braz J Microbiol. 2024 Aug 23. doi: 10.1007/s42770-024-01477-w. Online ahead of print. Braz J Microbiol. 2024. PMID: 39179891
Mangiferin potentiates the activity of antifungal agents against fluconazole-resistant Candida spp.
Ferreira TL, Leitão AC, da Silva LJ, do Amaral Valente Sá LG, de Farias Cabral VP, Rodrigues DS, Barbosa SA, de Andrade Neto JB, Barbosa AD, Almeida Moreira LE, França Rios ME, Cavalcanti BC, de Moraes MO, Nobre Júnior HV, da Silva CR. Ferreira TL, et al. Among authors: barbosa sa. Future Microbiol. 2024 Sep;19(13):1157-1170. doi: 10.1080/17460913.2024.2366627. Epub 2024 Jul 16. Future Microbiol. 2024. PMID: 39012219
Antifungal activity of propafenone on Candida spp. strains: interaction with antifungals and possible mechanism of action.
Barbosa AD, Leitão AC, de Oliveira LC, Rodrigues DS, de Farias Cabral VP, Moreira LEA, Silveira MJCB, Barbosa SA, de Souza BO, Sá LGDAV, de Andrade Neto JB, Cavalcanti BC, Magalhães IL, de Moraes MO, Júnior HVN, da Silva CR. Barbosa AD, et al. Among authors: barbosa sa. J Med Microbiol. 2024 Jul;73(7). doi: 10.1099/jmm.0.001850. J Med Microbiol. 2024. PMID: 38979984
30 results